Share Your Memories and Sympathies and Join the Bereaved!
Join a discussion and talk to others in the Sysoon community.
Jacinto Convit García was a Venezuelan physician and scientist, known for developing a vaccine in an attempt to fight leprosy and his studies to cure different types of cancer. He played a significant role in founding Venezuela's National Institute of Biomedicine and held many leprosy-related positions. Among Convit's many honors for his work on leprosy and tropical diseases was Spain's Prince of Asturias Award in the Scientific and Technical Research category and France's Legion of Honor. In 1988, Convit was nominated for a Nobel Prize in Medicine for his experimental anti-leprosy vaccine.
The Social Security Death Index includes over 200 million citizen death records. Enjoy free access to the most up-to-date SSDI search for individuals with International Social Security numbers. Search the SSDI online for free now or subscribe for access to billions of other genealogy records.
Note: Do you have a family photo of Jacinto Convit García? Consider uploading your photo of Jacinto Convit García so that your pictures are included in Jacinto Convit García's genealogy, family trees & family history records. Sysoon enables anyone to create a free online tribute for a much loved relative or friend who has passed away.
A memorial service for Jacinto Convit García. Information about event on Sysoon. [86212467-en]
we are preparing more information.
A funeral is a ceremony for celebrating, respecting, sanctifying, or remembering the life of a person who has died. [more about funeral]
Followers are people who receive the updates and information about the deceased person.
Address and location of Jacinto Convit García which have been published. Click on the address to view a map.
Jacinto Convit García was born in.
Jacinto Convit García died in.
Sticking a QR code to the headstone of a grave allows visitors to read the biography and view pictures of the deceased
What is: Memorial QR Code?
└─ Please, to post your comments.